Latest Clinical trials News

Former U.S. Rep. Chris Collins arrives at federal court for sentencing Friday, Jan. 17, 2020, in New York. Collins pleaded guilty last fall to insider trading and lying to the FBI. (AP Photo/Seth Wenig)

Ex-US Rep. Collins gets over 2 years in insider trading case

Jan. 17, 2020 10:30 PM EST

NEW YORK (AP) — The first member of Congress to endorse Donald Trump to be president was sentenced Friday to two years and two months in federal prison after admitting he helped his son and others dodge $800,000 in stock market losses when he learned that a drug trial by a small pharmaceutical company had...

In this Nov. 5, 2019 photo, in St. Francis, Wis., Amy Carter looks at her Yorkshire terrier-Chihuahua mix Bentley, who has epilepsy. Carter, gives him CBD, which she says has reduced his seizures. The federal government has yet to establish standards for CBD that will help pet owners know whether it works and how much to give. But the lack of regulation has not stopped some from buying it, fueling a $400 million CBD market for pets that grew more than tenfold since last year and is expected to reach $1.7 billion by 2023, according to the cannabis research firm Brightfield Group. (AP Photo/Carrie Antlfinger)

Researchers: Some pet products touted as CBD don't have any

Jan. 7, 2020 11:44 AM EST

Companies have unleashed hundreds of CBD pet health products accompanied by glowing customer testimonials claiming the cannabis derivative produced calmer, quieter and pain-free dogs and cats. But some of these products are all bark and no bite. “You'd be astounded by the analysis we've seen of products...

Rhode Island hospitals, Brown to research Alzheimer's drug

Dec. 10, 2019 6:24 PM EST

PROVIDENCE, R.I. (AP) — Researchers at Brown University and two Rhode Island hospitals announced they are researching a new drug to treat Alzheimer's disease. Brown, Butler Hospital and The Miriam Hospital are starting a phase-one clinical trial of emtricitabine, the three institutions announced Monday....

In this Nov. 19, 2019 photo provided by John Leyba shows Julia Vitarello visits her daughter Mila, who is fighting Batten disease, a rare fatal condition with no cure, in her room at Childrens Hospital in Aurora, Colo. Mila is the first person in the world to receive a drug customized for just one person. It was named Milasen. (John Leyba via AP)

Drug designed and manufactured for 9-year-old Boulder girl

Nov. 29, 2019 12:07 PM EST

DENVER (AP) — Mila Makovec has high pigtails in her dark hair and a cloth doll tucked under her arm as she wakes up in a hospital bed, where she’s just been injected with a one-of-a-kind drug intended to save her life. The drug works for only one person in the world — this 9-year-old girl...

Lab company bringing nearly 750 jobs to North Carolina

Nov. 27, 2019 12:42 PM EST

DURHAM, N.C. (AP) — North Carolina’s governor has announced that a clinical trial lab services provider will add 749 jobs at a new facility over the next few years. Gov. Roy Cooper issued a statement Wednesday that Q Squared Solutions LLC will invest $73 million in the Durham-based facility...